Promising new PrEP method undergoes first safety study for anal sex
Combinations containing TAF and cobicistat linked to physical depression symptoms in women with HIV
San Francisco shows that long-acting cabotegravir and rilpivirine may be feasible for people without viral suppression
Switching to injectable cabotegravir and rilpivirine rarely affects body weight
Sharing anti-HIV medication is common in rural Uganda
First, second, and third generation smallpox vaccines all protect against mpox infection
Dolutegravir plus darunavir superior to three-drug darunavir combination in second-line treatment
Good news for women and PrEP: quarterly dosing may work
Mpox (monkeypox) can be very severe in people with uncontrolled HIV
Mosaico trial closure shifts vaccine focus to neutralising antibodies
Prescribing doxyPEP after STI diagnosis is more efficient than targeting specific groups of people
Integrase inhibitors do not raise cardiovascular risk in people starting HIV treatment
Dapivirine vaginal ring safe to use in third trimester of pregnancy and during breastfeeding
Doxycycline PEP after sex appears ineffective for cisgender women
No marked increase in gonorrhoea resistance in doxyPEP study
Point-of-care viral load tests at delivery improve early preventive treatment for children at risk of HIV
Vaccine halves gonorrhoea rate in French study
German man remains free of HIV nearly 10 years after stem cell transplant
